118 related articles for article (PubMed ID: 29389071)
21. Monitoring Melanoma Using Circulating Free DNA.
Diefenbach RJ; Lee JH; Rizos H
Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893
[TBL] [Abstract][Full Text] [Related]
22. Genotyping of common EGFR mutations in lung cancer patients by electrochemical biosensor.
Weng XH; Xu XW; Wang CL; Lin WW; Liu AL; Chen W; Lin XH
J Pharm Biomed Anal; 2018 Feb; 150():176-182. PubMed ID: 29245087
[TBL] [Abstract][Full Text] [Related]
23. Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.
Bartels S; Persing S; Hasemeier B; Schipper E; Kreipe H; Lehmann U
J Mol Diagn; 2017 Sep; 19(5):722-732. PubMed ID: 28723342
[TBL] [Abstract][Full Text] [Related]
24. Piezoelectric Plate Sensor (PEPS) for Analysis of Specific KRAS Point Mutations at Low Copy Number in Urine Without DNA Isolation or Amplification.
Kirimli CE; Shih WH; Shih WY
Methods Mol Biol; 2017; 1572():327-348. PubMed ID: 28299698
[TBL] [Abstract][Full Text] [Related]
25. Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?
Kim ST; Jung HY; Sung JS; Jo UH; Tanaka T; Hagiwara K; Park KH; Shin SW; Kim JS; Kim YH
Am J Clin Oncol; 2013 Feb; 36(1):57-63. PubMed ID: 22237146
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.
Zhu L; Zhang S; Xun Y; Jiang Y; Xia B; Chen X; Wang L; Jiang H; Ma S
Pathol Oncol Res; 2018 Oct; 24(4):843-851. PubMed ID: 28868565
[TBL] [Abstract][Full Text] [Related]
27. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
28. Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
Pasquale R; Fenizia F; Esposito Abate R; Sacco A; Esposito C; Forgione L; Rachiglio AM; Bevilacqua S; Montanino A; Franco R; Rocco G; Botti G; Denis MG; Morabito A; De Luca A; Normanno N
Pharmacogenomics; 2015; 16(10):1135-48. PubMed ID: 26249748
[TBL] [Abstract][Full Text] [Related]
29. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
[TBL] [Abstract][Full Text] [Related]
30. The Dynamic Use of
Macías M; Alegre E; Alkorta-Aranburu G; Patiño-García A; Mateos B; Andueza MP; Gúrpide A; Lopez-Picazo JM; Gil-Bazo I; Perez-Gracia JL; González Á
Dis Markers; 2019; 2019():7954921. PubMed ID: 30809319
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays.
Jiang XW; Liu W; Zhu XY; Xu XX
Mol Med Rep; 2019 Jul; 20(1):593-603. PubMed ID: 31115577
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses.
Andersen RF
Expert Rev Mol Diagn; 2018 Dec; 18(12):1011-1019. PubMed ID: 30411633
[No Abstract] [Full Text] [Related]
33. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
34. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
[TBL] [Abstract][Full Text] [Related]
35. Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.
Kasahara N; Kenmotsu H; Serizawa M; Umehara R; Ono A; Hisamatsu Y; Wakuda K; Omori S; Nakashima K; Taira T; Naito T; Murakami H; Koh Y; Mori K; Endo M; Nakajima T; Yamada M; Kusuhara M; Takahashi T
Lung Cancer; 2017 Apr; 106():138-144. PubMed ID: 28285688
[TBL] [Abstract][Full Text] [Related]
36. Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Nicolazzo C; Raimondi C; Loreni F; Gazzaniga P; Gradilone A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629196
[TBL] [Abstract][Full Text] [Related]
37. PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
Han JY; Choi JJ; Kim JY; Han YL; Lee GK
BMC Cancer; 2016 Aug; 16():627. PubMed ID: 27519791
[TBL] [Abstract][Full Text] [Related]
38. A dual-signalling electrochemical DNA sensor based on target hybridization-induced change in DNA probe flexibility.
Yang W; Lai RY
Chem Commun (Camb); 2012 Sep; 48(69):8703-5. PubMed ID: 22825042
[TBL] [Abstract][Full Text] [Related]
39. Accurate Electrochemistry Analysis of Circulating Methylated DNA from Clinical Plasma Based on Paired-End Tagging and Amplifications.
Chen F; Wang X; Cao X; Zhao Y
Anal Chem; 2017 Oct; 89(19):10468-10473. PubMed ID: 28810735
[TBL] [Abstract][Full Text] [Related]
40. EGFR point mutation detection of single circulating tumor cells for lung cancer using a micro-well array.
Gao W; Zhang X; Yuan H; Wang Y; Zhou H; Jin H; Jia C; Jin Q; Cong H; Zhao J
Biosens Bioelectron; 2019 Aug; 139():111326. PubMed ID: 31129389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]